Global Cisatracurium Besylate Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Cisatracurium besylate is the latest generation of muscle relaxant. Compared with the major clinical muscle relaxants, this product has the characteristics of metabolism through non-hepatic and non-renal pathways and cardiovascular stability.Atracurium is mainly used in general anesthesia, and can be widely used in endotracheal intubation, liver and kidney dysfunction, cardiovascular surgery and elderly and pediatric patients.Since the drug was first marketed in the UK in 1996, it has gradually replaced vecuronium bromide and atracurium in foreign countries and become the mainstream of clinical muscle relaxants.
LPI (LP Information)' newest research report, the “Cisatracurium Besylate Industry Forecast” looks at past sales and reviews total world Cisatracurium Besylate sales in 2022, providing a comprehensive analysis by region and market sector of projected Cisatracurium Besylate sales for 2023 through 2029. With Cisatracurium Besylate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cisatracurium Besylate industry.
This Insight Report provides a comprehensive analysis of the global Cisatracurium Besylate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cisatracurium Besylate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cisatracurium Besylate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cisatracurium Besylate and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cisatracurium Besylate.
The global Cisatracurium Besylate market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cisatracurium Besylate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cisatracurium Besylate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cisatracurium Besylate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cisatracurium Besylate players cover GSK, Aspen Pharmacare, AbbVie, Abbott, Pfizer, Mylan Pharmaceuticals, Fresenius Kabi, Omega Laboratories Ltd and Somerset Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cisatracurium Besylate market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Cisatracurium Besylate market?
What factors are driving Cisatracurium Besylate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cisatracurium Besylate market opportunities vary by end market size?
How does Cisatracurium Besylate break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Cisatracurium besylate is the latest generation of muscle relaxant. Compared with the major clinical muscle relaxants, this product has the characteristics of metabolism through non-hepatic and non-renal pathways and cardiovascular stability.Atracurium is mainly used in general anesthesia, and can be widely used in endotracheal intubation, liver and kidney dysfunction, cardiovascular surgery and elderly and pediatric patients.Since the drug was first marketed in the UK in 1996, it has gradually replaced vecuronium bromide and atracurium in foreign countries and become the mainstream of clinical muscle relaxants.
LPI (LP Information)' newest research report, the “Cisatracurium Besylate Industry Forecast” looks at past sales and reviews total world Cisatracurium Besylate sales in 2022, providing a comprehensive analysis by region and market sector of projected Cisatracurium Besylate sales for 2023 through 2029. With Cisatracurium Besylate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cisatracurium Besylate industry.
This Insight Report provides a comprehensive analysis of the global Cisatracurium Besylate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cisatracurium Besylate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cisatracurium Besylate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cisatracurium Besylate and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cisatracurium Besylate.
The global Cisatracurium Besylate market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cisatracurium Besylate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cisatracurium Besylate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cisatracurium Besylate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cisatracurium Besylate players cover GSK, Aspen Pharmacare, AbbVie, Abbott, Pfizer, Mylan Pharmaceuticals, Fresenius Kabi, Omega Laboratories Ltd and Somerset Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cisatracurium Besylate market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Solution
- Injection
- General Anesthesia
- Endotracheal Intubation
- Liver And Kidney Dysfunction
- Cardiovascular Surgery
- Old Families
- Pediatric
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK
- Aspen Pharmacare
- AbbVie
- Abbott
- Pfizer
- Mylan Pharmaceuticals
- Fresenius Kabi
- Omega Laboratories Ltd
- Somerset Therapeutics
- Jiangsu Hengrui Medicine
- Shanghai Pharmaceuticals Holding
- Zhejiang Xianju
What is the 10-year outlook for the global Cisatracurium Besylate market?
What factors are driving Cisatracurium Besylate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cisatracurium Besylate market opportunities vary by end market size?
How does Cisatracurium Besylate break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cisatracurium Besylate Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Cisatracurium Besylate by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Cisatracurium Besylate by Country/Region, 2018, 2022 & 2029
2.2 Cisatracurium Besylate Segment by Type
2.2.1 Solution
2.2.2 Injection
2.3 Cisatracurium Besylate Sales by Type
2.3.1 Global Cisatracurium Besylate Sales Market Share by Type (2018-2023)
2.3.2 Global Cisatracurium Besylate Revenue and Market Share by Type (2018-2023)
2.3.3 Global Cisatracurium Besylate Sale Price by Type (2018-2023)
2.4 Cisatracurium Besylate Segment by Application
2.4.1 General Anesthesia
2.4.2 Endotracheal Intubation
2.4.3 Liver And Kidney Dysfunction
2.4.4 Cardiovascular Surgery
2.4.5 Old Families
2.4.6 Pediatric
2.4.7 Other
2.5 Cisatracurium Besylate Sales by Application
2.5.1 Global Cisatracurium Besylate Sale Market Share by Application (2018-2023)
2.5.2 Global Cisatracurium Besylate Revenue and Market Share by Application (2018-2023)
2.5.3 Global Cisatracurium Besylate Sale Price by Application (2018-2023)
3 GLOBAL CISATRACURIUM BESYLATE BY COMPANY
3.1 Global Cisatracurium Besylate Breakdown Data by Company
3.1.1 Global Cisatracurium Besylate Annual Sales by Company (2018-2023)
3.1.2 Global Cisatracurium Besylate Sales Market Share by Company (2018-2023)
3.2 Global Cisatracurium Besylate Annual Revenue by Company (2018-2023)
3.2.1 Global Cisatracurium Besylate Revenue by Company (2018-2023)
3.2.2 Global Cisatracurium Besylate Revenue Market Share by Company (2018-2023)
3.3 Global Cisatracurium Besylate Sale Price by Company
3.4 Key Manufacturers Cisatracurium Besylate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cisatracurium Besylate Product Location Distribution
3.4.2 Players Cisatracurium Besylate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CISATRACURIUM BESYLATE BY GEOGRAPHIC REGION
4.1 World Historic Cisatracurium Besylate Market Size by Geographic Region (2018-2023)
4.1.1 Global Cisatracurium Besylate Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Cisatracurium Besylate Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Cisatracurium Besylate Market Size by Country/Region (2018-2023)
4.2.1 Global Cisatracurium Besylate Annual Sales by Country/Region (2018-2023)
4.2.2 Global Cisatracurium Besylate Annual Revenue by Country/Region (2018-2023)
4.3 Americas Cisatracurium Besylate Sales Growth
4.4 APAC Cisatracurium Besylate Sales Growth
4.5 Europe Cisatracurium Besylate Sales Growth
4.6 Middle East & Africa Cisatracurium Besylate Sales Growth
5 AMERICAS
5.1 Americas Cisatracurium Besylate Sales by Country
5.1.1 Americas Cisatracurium Besylate Sales by Country (2018-2023)
5.1.2 Americas Cisatracurium Besylate Revenue by Country (2018-2023)
5.2 Americas Cisatracurium Besylate Sales by Type
5.3 Americas Cisatracurium Besylate Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cisatracurium Besylate Sales by Region
6.1.1 APAC Cisatracurium Besylate Sales by Region (2018-2023)
6.1.2 APAC Cisatracurium Besylate Revenue by Region (2018-2023)
6.2 APAC Cisatracurium Besylate Sales by Type
6.3 APAC Cisatracurium Besylate Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cisatracurium Besylate by Country
7.1.1 Europe Cisatracurium Besylate Sales by Country (2018-2023)
7.1.2 Europe Cisatracurium Besylate Revenue by Country (2018-2023)
7.2 Europe Cisatracurium Besylate Sales by Type
7.3 Europe Cisatracurium Besylate Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cisatracurium Besylate by Country
8.1.1 Middle East & Africa Cisatracurium Besylate Sales by Country (2018-2023)
8.1.2 Middle East & Africa Cisatracurium Besylate Revenue by Country (2018-2023)
8.2 Middle East & Africa Cisatracurium Besylate Sales by Type
8.3 Middle East & Africa Cisatracurium Besylate Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cisatracurium Besylate
10.3 Manufacturing Process Analysis of Cisatracurium Besylate
10.4 Industry Chain Structure of Cisatracurium Besylate
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cisatracurium Besylate Distributors
11.3 Cisatracurium Besylate Customer
12 WORLD FORECAST REVIEW FOR CISATRACURIUM BESYLATE BY GEOGRAPHIC REGION
12.1 Global Cisatracurium Besylate Market Size Forecast by Region
12.1.1 Global Cisatracurium Besylate Forecast by Region (2024-2029)
12.1.2 Global Cisatracurium Besylate Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cisatracurium Besylate Forecast by Type
12.7 Global Cisatracurium Besylate Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Cisatracurium Besylate Product Portfolios and Specifications
13.1.3 GSK Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Aspen Pharmacare
13.2.1 Aspen Pharmacare Company Information
13.2.2 Aspen Pharmacare Cisatracurium Besylate Product Portfolios and Specifications
13.2.3 Aspen Pharmacare Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Aspen Pharmacare Main Business Overview
13.2.5 Aspen Pharmacare Latest Developments
13.3 AbbVie
13.3.1 AbbVie Company Information
13.3.2 AbbVie Cisatracurium Besylate Product Portfolios and Specifications
13.3.3 AbbVie Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 AbbVie Main Business Overview
13.3.5 AbbVie Latest Developments
13.4 Abbott
13.4.1 Abbott Company Information
13.4.2 Abbott Cisatracurium Besylate Product Portfolios and Specifications
13.4.3 Abbott Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Abbott Main Business Overview
13.4.5 Abbott Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Cisatracurium Besylate Product Portfolios and Specifications
13.5.3 Pfizer Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Mylan Pharmaceuticals
13.6.1 Mylan Pharmaceuticals Company Information
13.6.2 Mylan Pharmaceuticals Cisatracurium Besylate Product Portfolios and Specifications
13.6.3 Mylan Pharmaceuticals Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Mylan Pharmaceuticals Main Business Overview
13.6.5 Mylan Pharmaceuticals Latest Developments
13.7 Fresenius Kabi
13.7.1 Fresenius Kabi Company Information
13.7.2 Fresenius Kabi Cisatracurium Besylate Product Portfolios and Specifications
13.7.3 Fresenius Kabi Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Fresenius Kabi Main Business Overview
13.7.5 Fresenius Kabi Latest Developments
13.8 Omega Laboratories Ltd
13.8.1 Omega Laboratories Ltd Company Information
13.8.2 Omega Laboratories Ltd Cisatracurium Besylate Product Portfolios and Specifications
13.8.3 Omega Laboratories Ltd Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Omega Laboratories Ltd Main Business Overview
13.8.5 Omega Laboratories Ltd Latest Developments
13.9 Somerset Therapeutics
13.9.1 Somerset Therapeutics Company Information
13.9.2 Somerset Therapeutics Cisatracurium Besylate Product Portfolios and Specifications
13.9.3 Somerset Therapeutics Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Somerset Therapeutics Main Business Overview
13.9.5 Somerset Therapeutics Latest Developments
13.10 Jiangsu Hengrui Medicine
13.10.1 Jiangsu Hengrui Medicine Company Information
13.10.2 Jiangsu Hengrui Medicine Cisatracurium Besylate Product Portfolios and Specifications
13.10.3 Jiangsu Hengrui Medicine Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Jiangsu Hengrui Medicine Main Business Overview
13.10.5 Jiangsu Hengrui Medicine Latest Developments
13.11 Shanghai Pharmaceuticals Holding
13.11.1 Shanghai Pharmaceuticals Holding Company Information
13.11.2 Shanghai Pharmaceuticals Holding Cisatracurium Besylate Product Portfolios and Specifications
13.11.3 Shanghai Pharmaceuticals Holding Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shanghai Pharmaceuticals Holding Main Business Overview
13.11.5 Shanghai Pharmaceuticals Holding Latest Developments
13.12 Zhejiang Xianju
13.12.1 Zhejiang Xianju Company Information
13.12.2 Zhejiang Xianju Cisatracurium Besylate Product Portfolios and Specifications
13.12.3 Zhejiang Xianju Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Zhejiang Xianju Main Business Overview
13.12.5 Zhejiang Xianju Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cisatracurium Besylate Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Cisatracurium Besylate by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Cisatracurium Besylate by Country/Region, 2018, 2022 & 2029
2.2 Cisatracurium Besylate Segment by Type
2.2.1 Solution
2.2.2 Injection
2.3 Cisatracurium Besylate Sales by Type
2.3.1 Global Cisatracurium Besylate Sales Market Share by Type (2018-2023)
2.3.2 Global Cisatracurium Besylate Revenue and Market Share by Type (2018-2023)
2.3.3 Global Cisatracurium Besylate Sale Price by Type (2018-2023)
2.4 Cisatracurium Besylate Segment by Application
2.4.1 General Anesthesia
2.4.2 Endotracheal Intubation
2.4.3 Liver And Kidney Dysfunction
2.4.4 Cardiovascular Surgery
2.4.5 Old Families
2.4.6 Pediatric
2.4.7 Other
2.5 Cisatracurium Besylate Sales by Application
2.5.1 Global Cisatracurium Besylate Sale Market Share by Application (2018-2023)
2.5.2 Global Cisatracurium Besylate Revenue and Market Share by Application (2018-2023)
2.5.3 Global Cisatracurium Besylate Sale Price by Application (2018-2023)
3 GLOBAL CISATRACURIUM BESYLATE BY COMPANY
3.1 Global Cisatracurium Besylate Breakdown Data by Company
3.1.1 Global Cisatracurium Besylate Annual Sales by Company (2018-2023)
3.1.2 Global Cisatracurium Besylate Sales Market Share by Company (2018-2023)
3.2 Global Cisatracurium Besylate Annual Revenue by Company (2018-2023)
3.2.1 Global Cisatracurium Besylate Revenue by Company (2018-2023)
3.2.2 Global Cisatracurium Besylate Revenue Market Share by Company (2018-2023)
3.3 Global Cisatracurium Besylate Sale Price by Company
3.4 Key Manufacturers Cisatracurium Besylate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cisatracurium Besylate Product Location Distribution
3.4.2 Players Cisatracurium Besylate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CISATRACURIUM BESYLATE BY GEOGRAPHIC REGION
4.1 World Historic Cisatracurium Besylate Market Size by Geographic Region (2018-2023)
4.1.1 Global Cisatracurium Besylate Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Cisatracurium Besylate Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Cisatracurium Besylate Market Size by Country/Region (2018-2023)
4.2.1 Global Cisatracurium Besylate Annual Sales by Country/Region (2018-2023)
4.2.2 Global Cisatracurium Besylate Annual Revenue by Country/Region (2018-2023)
4.3 Americas Cisatracurium Besylate Sales Growth
4.4 APAC Cisatracurium Besylate Sales Growth
4.5 Europe Cisatracurium Besylate Sales Growth
4.6 Middle East & Africa Cisatracurium Besylate Sales Growth
5 AMERICAS
5.1 Americas Cisatracurium Besylate Sales by Country
5.1.1 Americas Cisatracurium Besylate Sales by Country (2018-2023)
5.1.2 Americas Cisatracurium Besylate Revenue by Country (2018-2023)
5.2 Americas Cisatracurium Besylate Sales by Type
5.3 Americas Cisatracurium Besylate Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cisatracurium Besylate Sales by Region
6.1.1 APAC Cisatracurium Besylate Sales by Region (2018-2023)
6.1.2 APAC Cisatracurium Besylate Revenue by Region (2018-2023)
6.2 APAC Cisatracurium Besylate Sales by Type
6.3 APAC Cisatracurium Besylate Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cisatracurium Besylate by Country
7.1.1 Europe Cisatracurium Besylate Sales by Country (2018-2023)
7.1.2 Europe Cisatracurium Besylate Revenue by Country (2018-2023)
7.2 Europe Cisatracurium Besylate Sales by Type
7.3 Europe Cisatracurium Besylate Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cisatracurium Besylate by Country
8.1.1 Middle East & Africa Cisatracurium Besylate Sales by Country (2018-2023)
8.1.2 Middle East & Africa Cisatracurium Besylate Revenue by Country (2018-2023)
8.2 Middle East & Africa Cisatracurium Besylate Sales by Type
8.3 Middle East & Africa Cisatracurium Besylate Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cisatracurium Besylate
10.3 Manufacturing Process Analysis of Cisatracurium Besylate
10.4 Industry Chain Structure of Cisatracurium Besylate
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cisatracurium Besylate Distributors
11.3 Cisatracurium Besylate Customer
12 WORLD FORECAST REVIEW FOR CISATRACURIUM BESYLATE BY GEOGRAPHIC REGION
12.1 Global Cisatracurium Besylate Market Size Forecast by Region
12.1.1 Global Cisatracurium Besylate Forecast by Region (2024-2029)
12.1.2 Global Cisatracurium Besylate Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cisatracurium Besylate Forecast by Type
12.7 Global Cisatracurium Besylate Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Cisatracurium Besylate Product Portfolios and Specifications
13.1.3 GSK Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Aspen Pharmacare
13.2.1 Aspen Pharmacare Company Information
13.2.2 Aspen Pharmacare Cisatracurium Besylate Product Portfolios and Specifications
13.2.3 Aspen Pharmacare Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Aspen Pharmacare Main Business Overview
13.2.5 Aspen Pharmacare Latest Developments
13.3 AbbVie
13.3.1 AbbVie Company Information
13.3.2 AbbVie Cisatracurium Besylate Product Portfolios and Specifications
13.3.3 AbbVie Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 AbbVie Main Business Overview
13.3.5 AbbVie Latest Developments
13.4 Abbott
13.4.1 Abbott Company Information
13.4.2 Abbott Cisatracurium Besylate Product Portfolios and Specifications
13.4.3 Abbott Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Abbott Main Business Overview
13.4.5 Abbott Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Cisatracurium Besylate Product Portfolios and Specifications
13.5.3 Pfizer Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Mylan Pharmaceuticals
13.6.1 Mylan Pharmaceuticals Company Information
13.6.2 Mylan Pharmaceuticals Cisatracurium Besylate Product Portfolios and Specifications
13.6.3 Mylan Pharmaceuticals Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Mylan Pharmaceuticals Main Business Overview
13.6.5 Mylan Pharmaceuticals Latest Developments
13.7 Fresenius Kabi
13.7.1 Fresenius Kabi Company Information
13.7.2 Fresenius Kabi Cisatracurium Besylate Product Portfolios and Specifications
13.7.3 Fresenius Kabi Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Fresenius Kabi Main Business Overview
13.7.5 Fresenius Kabi Latest Developments
13.8 Omega Laboratories Ltd
13.8.1 Omega Laboratories Ltd Company Information
13.8.2 Omega Laboratories Ltd Cisatracurium Besylate Product Portfolios and Specifications
13.8.3 Omega Laboratories Ltd Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Omega Laboratories Ltd Main Business Overview
13.8.5 Omega Laboratories Ltd Latest Developments
13.9 Somerset Therapeutics
13.9.1 Somerset Therapeutics Company Information
13.9.2 Somerset Therapeutics Cisatracurium Besylate Product Portfolios and Specifications
13.9.3 Somerset Therapeutics Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Somerset Therapeutics Main Business Overview
13.9.5 Somerset Therapeutics Latest Developments
13.10 Jiangsu Hengrui Medicine
13.10.1 Jiangsu Hengrui Medicine Company Information
13.10.2 Jiangsu Hengrui Medicine Cisatracurium Besylate Product Portfolios and Specifications
13.10.3 Jiangsu Hengrui Medicine Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Jiangsu Hengrui Medicine Main Business Overview
13.10.5 Jiangsu Hengrui Medicine Latest Developments
13.11 Shanghai Pharmaceuticals Holding
13.11.1 Shanghai Pharmaceuticals Holding Company Information
13.11.2 Shanghai Pharmaceuticals Holding Cisatracurium Besylate Product Portfolios and Specifications
13.11.3 Shanghai Pharmaceuticals Holding Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shanghai Pharmaceuticals Holding Main Business Overview
13.11.5 Shanghai Pharmaceuticals Holding Latest Developments
13.12 Zhejiang Xianju
13.12.1 Zhejiang Xianju Company Information
13.12.2 Zhejiang Xianju Cisatracurium Besylate Product Portfolios and Specifications
13.12.3 Zhejiang Xianju Cisatracurium Besylate Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Zhejiang Xianju Main Business Overview
13.12.5 Zhejiang Xianju Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cisatracurium Besylate Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Cisatracurium Besylate Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Solution
Table 4. Major Players of Injection
Table 5. Global Cisatracurium Besylate Sales by Type (2018-2023) & (Litre)
Table 6. Global Cisatracurium Besylate Sales Market Share by Type (2018-2023)
Table 7. Global Cisatracurium Besylate Revenue by Type (2018-2023) & ($ million)
Table 8. Global Cisatracurium Besylate Revenue Market Share by Type (2018-2023)
Table 9. Global Cisatracurium Besylate Sale Price by Type (2018-2023) & (US$/ML)
Table 10. Global Cisatracurium Besylate Sales by Application (2018-2023) & (Litre)
Table 11. Global Cisatracurium Besylate Sales Market Share by Application (2018-2023)
Table 12. Global Cisatracurium Besylate Revenue by Application (2018-2023)
Table 13. Global Cisatracurium Besylate Revenue Market Share by Application (2018-2023)
Table 14. Global Cisatracurium Besylate Sale Price by Application (2018-2023) & (US$/ML)
Table 15. Global Cisatracurium Besylate Sales by Company (2018-2023) & (Litre)
Table 16. Global Cisatracurium Besylate Sales Market Share by Company (2018-2023)
Table 17. Global Cisatracurium Besylate Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Cisatracurium Besylate Revenue Market Share by Company (2018-2023)
Table 19. Global Cisatracurium Besylate Sale Price by Company (2018-2023) & (US$/ML)
Table 20. Key Manufacturers Cisatracurium Besylate Producing Area Distribution and Sales Area
Table 21. Players Cisatracurium Besylate Products Offered
Table 22. Cisatracurium Besylate Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Cisatracurium Besylate Sales by Geographic Region (2018-2023) & (Litre)
Table 26. Global Cisatracurium Besylate Sales Market Share Geographic Region (2018-2023)
Table 27. Global Cisatracurium Besylate Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Cisatracurium Besylate Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Cisatracurium Besylate Sales by Country/Region (2018-2023) & (Litre)
Table 30. Global Cisatracurium Besylate Sales Market Share by Country/Region (2018-2023)
Table 31. Global Cisatracurium Besylate Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Cisatracurium Besylate Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Cisatracurium Besylate Sales by Country (2018-2023) & (Litre)
Table 34. Americas Cisatracurium Besylate Sales Market Share by Country (2018-2023)
Table 35. Americas Cisatracurium Besylate Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Cisatracurium Besylate Revenue Market Share by Country (2018-2023)
Table 37. Americas Cisatracurium Besylate Sales by Type (2018-2023) & (Litre)
Table 38. Americas Cisatracurium Besylate Sales by Application (2018-2023) & (Litre)
Table 39. APAC Cisatracurium Besylate Sales by Region (2018-2023) & (Litre)
Table 40. APAC Cisatracurium Besylate Sales Market Share by Region (2018-2023)
Table 41. APAC Cisatracurium Besylate Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Cisatracurium Besylate Revenue Market Share by Region (2018-2023)
Table 43. APAC Cisatracurium Besylate Sales by Type (2018-2023) & (Litre)
Table 44. APAC Cisatracurium Besylate Sales by Application (2018-2023) & (Litre)
Table 45. Europe Cisatracurium Besylate Sales by Country (2018-2023) & (Litre)
Table 46. Europe Cisatracurium Besylate Sales Market Share by Country (2018-2023)
Table 47. Europe Cisatracurium Besylate Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Cisatracurium Besylate Revenue Market Share by Country (2018-2023)
Table 49. Europe Cisatracurium Besylate Sales by Type (2018-2023) & (Litre)
Table 50. Europe Cisatracurium Besylate Sales by Application (2018-2023) & (Litre)
Table 51. Middle East & Africa Cisatracurium Besylate Sales by Country (2018-2023) & (Litre)
Table 52. Middle East & Africa Cisatracurium Besylate Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Cisatracurium Besylate Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Cisatracurium Besylate Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Cisatracurium Besylate Sales by Type (2018-2023) & (Litre)
Table 56. Middle East & Africa Cisatracurium Besylate Sales by Application (2018-2023) & (Litre)
Table 57. Key Market Drivers & Growth Opportunities of Cisatracurium Besylate
Table 58. Key Market Challenges & Risks of Cisatracurium Besylate
Table 59. Key Industry Trends of Cisatracurium Besylate
Table 60. Cisatracurium Besylate Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Cisatracurium Besylate Distributors List
Table 63. Cisatracurium Besylate Customer List
Table 64. Global Cisatracurium Besylate Sales Forecast by Region (2024-2029) & (Litre)
Table 65. Global Cisatracurium Besylate Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Cisatracurium Besylate Sales Forecast by Country (2024-2029) & (Litre)
Table 67. Americas Cisatracurium Besylate Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Cisatracurium Besylate Sales Forecast by Region (2024-2029) & (Litre)
Table 69. APAC Cisatracurium Besylate Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Cisatracurium Besylate Sales Forecast by Country (2024-2029) & (Litre)
Table 71. Europe Cisatracurium Besylate Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Cisatracurium Besylate Sales Forecast by Country (2024-2029) & (Litre)
Table 73. Middle East & Africa Cisatracurium Besylate Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Cisatracurium Besylate Sales Forecast by Type (2024-2029) & (Litre)
Table 75. Global Cisatracurium Besylate Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Cisatracurium Besylate Sales Forecast by Application (2024-2029) & (Litre)
Table 77. Global Cisatracurium Besylate Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. GSK Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK Cisatracurium Besylate Product Portfolios and Specifications
Table 80. GSK Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. Aspen Pharmacare Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 84. Aspen Pharmacare Cisatracurium Besylate Product Portfolios and Specifications
Table 85. Aspen Pharmacare Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 86. Aspen Pharmacare Main Business
Table 87. Aspen Pharmacare Latest Developments
Table 88. AbbVie Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 89. AbbVie Cisatracurium Besylate Product Portfolios and Specifications
Table 90. AbbVie Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 91. AbbVie Main Business
Table 92. AbbVie Latest Developments
Table 93. Abbott Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 94. Abbott Cisatracurium Besylate Product Portfolios and Specifications
Table 95. Abbott Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 96. Abbott Main Business
Table 97. Abbott Latest Developments
Table 98. Pfizer Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 99. Pfizer Cisatracurium Besylate Product Portfolios and Specifications
Table 100. Pfizer Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 101. Pfizer Main Business
Table 102. Pfizer Latest Developments
Table 103. Mylan Pharmaceuticals Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 104. Mylan Pharmaceuticals Cisatracurium Besylate Product Portfolios and Specifications
Table 105. Mylan Pharmaceuticals Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 106. Mylan Pharmaceuticals Main Business
Table 107. Mylan Pharmaceuticals Latest Developments
Table 108. Fresenius Kabi Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 109. Fresenius Kabi Cisatracurium Besylate Product Portfolios and Specifications
Table 110. Fresenius Kabi Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 111. Fresenius Kabi Main Business
Table 112. Fresenius Kabi Latest Developments
Table 113. Omega Laboratories Ltd Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 114. Omega Laboratories Ltd Cisatracurium Besylate Product Portfolios and Specifications
Table 115. Omega Laboratories Ltd Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 116. Omega Laboratories Ltd Main Business
Table 117. Omega Laboratories Ltd Latest Developments
Table 118. Somerset Therapeutics Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 119. Somerset Therapeutics Cisatracurium Besylate Product Portfolios and Specifications
Table 120. Somerset Therapeutics Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 121. Somerset Therapeutics Main Business
Table 122. Somerset Therapeutics Latest Developments
Table 123. Jiangsu Hengrui Medicine Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 124. Jiangsu Hengrui Medicine Cisatracurium Besylate Product Portfolios and Specifications
Table 125. Jiangsu Hengrui Medicine Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 126. Jiangsu Hengrui Medicine Main Business
Table 127. Jiangsu Hengrui Medicine Latest Developments
Table 128. Shanghai Pharmaceuticals Holding Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 129. Shanghai Pharmaceuticals Holding Cisatracurium Besylate Product Portfolios and Specifications
Table 130. Shanghai Pharmaceuticals Holding Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 131. Shanghai Pharmaceuticals Holding Main Business
Table 132. Shanghai Pharmaceuticals Holding Latest Developments
Table 133. Zhejiang Xianju Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 134. Zhejiang Xianju Cisatracurium Besylate Product Portfolios and Specifications
Table 135. Zhejiang Xianju Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 136. Zhejiang Xianju Main Business
Table 137. Zhejiang Xianju Latest Developments
Table 1. Cisatracurium Besylate Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Cisatracurium Besylate Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Solution
Table 4. Major Players of Injection
Table 5. Global Cisatracurium Besylate Sales by Type (2018-2023) & (Litre)
Table 6. Global Cisatracurium Besylate Sales Market Share by Type (2018-2023)
Table 7. Global Cisatracurium Besylate Revenue by Type (2018-2023) & ($ million)
Table 8. Global Cisatracurium Besylate Revenue Market Share by Type (2018-2023)
Table 9. Global Cisatracurium Besylate Sale Price by Type (2018-2023) & (US$/ML)
Table 10. Global Cisatracurium Besylate Sales by Application (2018-2023) & (Litre)
Table 11. Global Cisatracurium Besylate Sales Market Share by Application (2018-2023)
Table 12. Global Cisatracurium Besylate Revenue by Application (2018-2023)
Table 13. Global Cisatracurium Besylate Revenue Market Share by Application (2018-2023)
Table 14. Global Cisatracurium Besylate Sale Price by Application (2018-2023) & (US$/ML)
Table 15. Global Cisatracurium Besylate Sales by Company (2018-2023) & (Litre)
Table 16. Global Cisatracurium Besylate Sales Market Share by Company (2018-2023)
Table 17. Global Cisatracurium Besylate Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Cisatracurium Besylate Revenue Market Share by Company (2018-2023)
Table 19. Global Cisatracurium Besylate Sale Price by Company (2018-2023) & (US$/ML)
Table 20. Key Manufacturers Cisatracurium Besylate Producing Area Distribution and Sales Area
Table 21. Players Cisatracurium Besylate Products Offered
Table 22. Cisatracurium Besylate Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Cisatracurium Besylate Sales by Geographic Region (2018-2023) & (Litre)
Table 26. Global Cisatracurium Besylate Sales Market Share Geographic Region (2018-2023)
Table 27. Global Cisatracurium Besylate Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Cisatracurium Besylate Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Cisatracurium Besylate Sales by Country/Region (2018-2023) & (Litre)
Table 30. Global Cisatracurium Besylate Sales Market Share by Country/Region (2018-2023)
Table 31. Global Cisatracurium Besylate Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Cisatracurium Besylate Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Cisatracurium Besylate Sales by Country (2018-2023) & (Litre)
Table 34. Americas Cisatracurium Besylate Sales Market Share by Country (2018-2023)
Table 35. Americas Cisatracurium Besylate Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Cisatracurium Besylate Revenue Market Share by Country (2018-2023)
Table 37. Americas Cisatracurium Besylate Sales by Type (2018-2023) & (Litre)
Table 38. Americas Cisatracurium Besylate Sales by Application (2018-2023) & (Litre)
Table 39. APAC Cisatracurium Besylate Sales by Region (2018-2023) & (Litre)
Table 40. APAC Cisatracurium Besylate Sales Market Share by Region (2018-2023)
Table 41. APAC Cisatracurium Besylate Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Cisatracurium Besylate Revenue Market Share by Region (2018-2023)
Table 43. APAC Cisatracurium Besylate Sales by Type (2018-2023) & (Litre)
Table 44. APAC Cisatracurium Besylate Sales by Application (2018-2023) & (Litre)
Table 45. Europe Cisatracurium Besylate Sales by Country (2018-2023) & (Litre)
Table 46. Europe Cisatracurium Besylate Sales Market Share by Country (2018-2023)
Table 47. Europe Cisatracurium Besylate Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Cisatracurium Besylate Revenue Market Share by Country (2018-2023)
Table 49. Europe Cisatracurium Besylate Sales by Type (2018-2023) & (Litre)
Table 50. Europe Cisatracurium Besylate Sales by Application (2018-2023) & (Litre)
Table 51. Middle East & Africa Cisatracurium Besylate Sales by Country (2018-2023) & (Litre)
Table 52. Middle East & Africa Cisatracurium Besylate Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Cisatracurium Besylate Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Cisatracurium Besylate Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Cisatracurium Besylate Sales by Type (2018-2023) & (Litre)
Table 56. Middle East & Africa Cisatracurium Besylate Sales by Application (2018-2023) & (Litre)
Table 57. Key Market Drivers & Growth Opportunities of Cisatracurium Besylate
Table 58. Key Market Challenges & Risks of Cisatracurium Besylate
Table 59. Key Industry Trends of Cisatracurium Besylate
Table 60. Cisatracurium Besylate Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Cisatracurium Besylate Distributors List
Table 63. Cisatracurium Besylate Customer List
Table 64. Global Cisatracurium Besylate Sales Forecast by Region (2024-2029) & (Litre)
Table 65. Global Cisatracurium Besylate Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Cisatracurium Besylate Sales Forecast by Country (2024-2029) & (Litre)
Table 67. Americas Cisatracurium Besylate Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Cisatracurium Besylate Sales Forecast by Region (2024-2029) & (Litre)
Table 69. APAC Cisatracurium Besylate Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Cisatracurium Besylate Sales Forecast by Country (2024-2029) & (Litre)
Table 71. Europe Cisatracurium Besylate Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Cisatracurium Besylate Sales Forecast by Country (2024-2029) & (Litre)
Table 73. Middle East & Africa Cisatracurium Besylate Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Cisatracurium Besylate Sales Forecast by Type (2024-2029) & (Litre)
Table 75. Global Cisatracurium Besylate Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Cisatracurium Besylate Sales Forecast by Application (2024-2029) & (Litre)
Table 77. Global Cisatracurium Besylate Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. GSK Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK Cisatracurium Besylate Product Portfolios and Specifications
Table 80. GSK Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. Aspen Pharmacare Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 84. Aspen Pharmacare Cisatracurium Besylate Product Portfolios and Specifications
Table 85. Aspen Pharmacare Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 86. Aspen Pharmacare Main Business
Table 87. Aspen Pharmacare Latest Developments
Table 88. AbbVie Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 89. AbbVie Cisatracurium Besylate Product Portfolios and Specifications
Table 90. AbbVie Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 91. AbbVie Main Business
Table 92. AbbVie Latest Developments
Table 93. Abbott Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 94. Abbott Cisatracurium Besylate Product Portfolios and Specifications
Table 95. Abbott Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 96. Abbott Main Business
Table 97. Abbott Latest Developments
Table 98. Pfizer Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 99. Pfizer Cisatracurium Besylate Product Portfolios and Specifications
Table 100. Pfizer Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 101. Pfizer Main Business
Table 102. Pfizer Latest Developments
Table 103. Mylan Pharmaceuticals Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 104. Mylan Pharmaceuticals Cisatracurium Besylate Product Portfolios and Specifications
Table 105. Mylan Pharmaceuticals Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 106. Mylan Pharmaceuticals Main Business
Table 107. Mylan Pharmaceuticals Latest Developments
Table 108. Fresenius Kabi Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 109. Fresenius Kabi Cisatracurium Besylate Product Portfolios and Specifications
Table 110. Fresenius Kabi Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 111. Fresenius Kabi Main Business
Table 112. Fresenius Kabi Latest Developments
Table 113. Omega Laboratories Ltd Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 114. Omega Laboratories Ltd Cisatracurium Besylate Product Portfolios and Specifications
Table 115. Omega Laboratories Ltd Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 116. Omega Laboratories Ltd Main Business
Table 117. Omega Laboratories Ltd Latest Developments
Table 118. Somerset Therapeutics Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 119. Somerset Therapeutics Cisatracurium Besylate Product Portfolios and Specifications
Table 120. Somerset Therapeutics Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 121. Somerset Therapeutics Main Business
Table 122. Somerset Therapeutics Latest Developments
Table 123. Jiangsu Hengrui Medicine Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 124. Jiangsu Hengrui Medicine Cisatracurium Besylate Product Portfolios and Specifications
Table 125. Jiangsu Hengrui Medicine Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 126. Jiangsu Hengrui Medicine Main Business
Table 127. Jiangsu Hengrui Medicine Latest Developments
Table 128. Shanghai Pharmaceuticals Holding Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 129. Shanghai Pharmaceuticals Holding Cisatracurium Besylate Product Portfolios and Specifications
Table 130. Shanghai Pharmaceuticals Holding Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 131. Shanghai Pharmaceuticals Holding Main Business
Table 132. Shanghai Pharmaceuticals Holding Latest Developments
Table 133. Zhejiang Xianju Basic Information, Cisatracurium Besylate Manufacturing Base, Sales Area and Its Competitors
Table 134. Zhejiang Xianju Cisatracurium Besylate Product Portfolios and Specifications
Table 135. Zhejiang Xianju Cisatracurium Besylate Sales (Litre), Revenue ($ Million), Price (US$/ML) and Gross Margin (2018-2023)
Table 136. Zhejiang Xianju Main Business
Table 137. Zhejiang Xianju Latest Developments
LIST OF FIGURES
Figure 1. Picture of Cisatracurium Besylate
Figure 2. Cisatracurium Besylate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cisatracurium Besylate Sales Growth Rate 2018-2029 (Litre)
Figure 7. Global Cisatracurium Besylate Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Cisatracurium Besylate Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Solution
Figure 10. Product Picture of Injection
Figure 11. Global Cisatracurium Besylate Sales Market Share by Type in 2022
Figure 12. Global Cisatracurium Besylate Revenue Market Share by Type (2018-2023)
Figure 13. Cisatracurium Besylate Consumed in General Anesthesia
Figure 14. Global Cisatracurium Besylate Market: General Anesthesia (2018-2023) & (Litre)
Figure 15. Cisatracurium Besylate Consumed in Endotracheal Intubation
Figure 16. Global Cisatracurium Besylate Market: Endotracheal Intubation (2018-2023) & (Litre)
Figure 17. Cisatracurium Besylate Consumed in Liver And Kidney Dysfunction
Figure 18. Global Cisatracurium Besylate Market: Liver And Kidney Dysfunction (2018-2023) & (Litre)
Figure 19. Cisatracurium Besylate Consumed in Cardiovascular Surgery
Figure 20. Global Cisatracurium Besylate Market: Cardiovascular Surgery (2018-2023) & (Litre)
Figure 21. Cisatracurium Besylate Consumed in Old Families
Figure 22. Global Cisatracurium Besylate Market: Old Families (2018-2023) & (Litre)
Figure 23. Cisatracurium Besylate Consumed in Pediatric
Figure 24. Global Cisatracurium Besylate Market: Pediatric (2018-2023) & (Litre)
Figure 25. Cisatracurium Besylate Consumed in Other
Figure 26. Global Cisatracurium Besylate Market: Other (2018-2023) & (Litre)
Figure 27. Global Cisatracurium Besylate Sales Market Share by Application (2022)
Figure 28. Global Cisatracurium Besylate Revenue Market Share by Application in 2022
Figure 29. Cisatracurium Besylate Sales Market by Company in 2022 (Litre)
Figure 30. Global Cisatracurium Besylate Sales Market Share by Company in 2022
Figure 31. Cisatracurium Besylate Revenue Market by Company in 2022 ($ Million)
Figure 32. Global Cisatracurium Besylate Revenue Market Share by Company in 2022
Figure 33. Global Cisatracurium Besylate Sales Market Share by Geographic Region (2018-2023)
Figure 34. Global Cisatracurium Besylate Revenue Market Share by Geographic Region in 2022
Figure 35. Americas Cisatracurium Besylate Sales 2018-2023 (Litre)
Figure 36. Americas Cisatracurium Besylate Revenue 2018-2023 ($ Millions)
Figure 37. APAC Cisatracurium Besylate Sales 2018-2023 (Litre)
Figure 38. APAC Cisatracurium Besylate Revenue 2018-2023 ($ Millions)
Figure 39. Europe Cisatracurium Besylate Sales 2018-2023 (Litre)
Figure 40. Europe Cisatracurium Besylate Revenue 2018-2023 ($ Millions)
Figure 41. Middle East & Africa Cisatracurium Besylate Sales 2018-2023 (Litre)
Figure 42. Middle East & Africa Cisatracurium Besylate Revenue 2018-2023 ($ Millions)
Figure 43. Americas Cisatracurium Besylate Sales Market Share by Country in 2022
Figure 44. Americas Cisatracurium Besylate Revenue Market Share by Country in 2022
Figure 45. Americas Cisatracurium Besylate Sales Market Share by Type (2018-2023)
Figure 46. Americas Cisatracurium Besylate Sales Market Share by Application (2018-2023)
Figure 47. United States Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 48. Canada Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 49. Mexico Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 50. Brazil Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 51. APAC Cisatracurium Besylate Sales Market Share by Region in 2022
Figure 52. APAC Cisatracurium Besylate Revenue Market Share by Regions in 2022
Figure 53. APAC Cisatracurium Besylate Sales Market Share by Type (2018-2023)
Figure 54. APAC Cisatracurium Besylate Sales Market Share by Application (2018-2023)
Figure 55. China Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 56. Japan Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 57. South Korea Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 58. Southeast Asia Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 59. India Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 60. Australia Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 61. China Taiwan Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 62. Europe Cisatracurium Besylate Sales Market Share by Country in 2022
Figure 63. Europe Cisatracurium Besylate Revenue Market Share by Country in 2022
Figure 64. Europe Cisatracurium Besylate Sales Market Share by Type (2018-2023)
Figure 65. Europe Cisatracurium Besylate Sales Market Share by Application (2018-2023)
Figure 66. Germany Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 67. France Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 68. UK Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 69. Italy Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 70. Russia Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 71. Middle East & Africa Cisatracurium Besylate Sales Market Share by Country in 2022
Figure 72. Middle East & Africa Cisatracurium Besylate Revenue Market Share by Country in 2022
Figure 73. Middle East & Africa Cisatracurium Besylate Sales Market Share by Type (2018-2023)
Figure 74. Middle East & Africa Cisatracurium Besylate Sales Market Share by Application (2018-2023)
Figure 75. Egypt Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 76. South Africa Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 77. Israel Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 78. Turkey Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 79. GCC Country Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 80. Manufacturing Cost Structure Analysis of Cisatracurium Besylate in 2022
Figure 81. Manufacturing Process Analysis of Cisatracurium Besylate
Figure 82. Industry Chain Structure of Cisatracurium Besylate
Figure 83. Channels of Distribution
Figure 84. Global Cisatracurium Besylate Sales Market Forecast by Region (2024-2029)
Figure 85. Global Cisatracurium Besylate Revenue Market Share Forecast by Region (2024-2029)
Figure 86. Global Cisatracurium Besylate Sales Market Share Forecast by Type (2024-2029)
Figure 87. Global Cisatracurium Besylate Revenue Market Share Forecast by Type (2024-2029)
Figure 88. Global Cisatracurium Besylate Sales Market Share Forecast by Application (2024-2029)
Figure 89. Global Cisatracurium Besylate Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Cisatracurium Besylate
Figure 2. Cisatracurium Besylate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cisatracurium Besylate Sales Growth Rate 2018-2029 (Litre)
Figure 7. Global Cisatracurium Besylate Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Cisatracurium Besylate Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Solution
Figure 10. Product Picture of Injection
Figure 11. Global Cisatracurium Besylate Sales Market Share by Type in 2022
Figure 12. Global Cisatracurium Besylate Revenue Market Share by Type (2018-2023)
Figure 13. Cisatracurium Besylate Consumed in General Anesthesia
Figure 14. Global Cisatracurium Besylate Market: General Anesthesia (2018-2023) & (Litre)
Figure 15. Cisatracurium Besylate Consumed in Endotracheal Intubation
Figure 16. Global Cisatracurium Besylate Market: Endotracheal Intubation (2018-2023) & (Litre)
Figure 17. Cisatracurium Besylate Consumed in Liver And Kidney Dysfunction
Figure 18. Global Cisatracurium Besylate Market: Liver And Kidney Dysfunction (2018-2023) & (Litre)
Figure 19. Cisatracurium Besylate Consumed in Cardiovascular Surgery
Figure 20. Global Cisatracurium Besylate Market: Cardiovascular Surgery (2018-2023) & (Litre)
Figure 21. Cisatracurium Besylate Consumed in Old Families
Figure 22. Global Cisatracurium Besylate Market: Old Families (2018-2023) & (Litre)
Figure 23. Cisatracurium Besylate Consumed in Pediatric
Figure 24. Global Cisatracurium Besylate Market: Pediatric (2018-2023) & (Litre)
Figure 25. Cisatracurium Besylate Consumed in Other
Figure 26. Global Cisatracurium Besylate Market: Other (2018-2023) & (Litre)
Figure 27. Global Cisatracurium Besylate Sales Market Share by Application (2022)
Figure 28. Global Cisatracurium Besylate Revenue Market Share by Application in 2022
Figure 29. Cisatracurium Besylate Sales Market by Company in 2022 (Litre)
Figure 30. Global Cisatracurium Besylate Sales Market Share by Company in 2022
Figure 31. Cisatracurium Besylate Revenue Market by Company in 2022 ($ Million)
Figure 32. Global Cisatracurium Besylate Revenue Market Share by Company in 2022
Figure 33. Global Cisatracurium Besylate Sales Market Share by Geographic Region (2018-2023)
Figure 34. Global Cisatracurium Besylate Revenue Market Share by Geographic Region in 2022
Figure 35. Americas Cisatracurium Besylate Sales 2018-2023 (Litre)
Figure 36. Americas Cisatracurium Besylate Revenue 2018-2023 ($ Millions)
Figure 37. APAC Cisatracurium Besylate Sales 2018-2023 (Litre)
Figure 38. APAC Cisatracurium Besylate Revenue 2018-2023 ($ Millions)
Figure 39. Europe Cisatracurium Besylate Sales 2018-2023 (Litre)
Figure 40. Europe Cisatracurium Besylate Revenue 2018-2023 ($ Millions)
Figure 41. Middle East & Africa Cisatracurium Besylate Sales 2018-2023 (Litre)
Figure 42. Middle East & Africa Cisatracurium Besylate Revenue 2018-2023 ($ Millions)
Figure 43. Americas Cisatracurium Besylate Sales Market Share by Country in 2022
Figure 44. Americas Cisatracurium Besylate Revenue Market Share by Country in 2022
Figure 45. Americas Cisatracurium Besylate Sales Market Share by Type (2018-2023)
Figure 46. Americas Cisatracurium Besylate Sales Market Share by Application (2018-2023)
Figure 47. United States Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 48. Canada Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 49. Mexico Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 50. Brazil Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 51. APAC Cisatracurium Besylate Sales Market Share by Region in 2022
Figure 52. APAC Cisatracurium Besylate Revenue Market Share by Regions in 2022
Figure 53. APAC Cisatracurium Besylate Sales Market Share by Type (2018-2023)
Figure 54. APAC Cisatracurium Besylate Sales Market Share by Application (2018-2023)
Figure 55. China Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 56. Japan Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 57. South Korea Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 58. Southeast Asia Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 59. India Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 60. Australia Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 61. China Taiwan Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 62. Europe Cisatracurium Besylate Sales Market Share by Country in 2022
Figure 63. Europe Cisatracurium Besylate Revenue Market Share by Country in 2022
Figure 64. Europe Cisatracurium Besylate Sales Market Share by Type (2018-2023)
Figure 65. Europe Cisatracurium Besylate Sales Market Share by Application (2018-2023)
Figure 66. Germany Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 67. France Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 68. UK Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 69. Italy Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 70. Russia Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 71. Middle East & Africa Cisatracurium Besylate Sales Market Share by Country in 2022
Figure 72. Middle East & Africa Cisatracurium Besylate Revenue Market Share by Country in 2022
Figure 73. Middle East & Africa Cisatracurium Besylate Sales Market Share by Type (2018-2023)
Figure 74. Middle East & Africa Cisatracurium Besylate Sales Market Share by Application (2018-2023)
Figure 75. Egypt Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 76. South Africa Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 77. Israel Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 78. Turkey Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 79. GCC Country Cisatracurium Besylate Revenue Growth 2018-2023 ($ Millions)
Figure 80. Manufacturing Cost Structure Analysis of Cisatracurium Besylate in 2022
Figure 81. Manufacturing Process Analysis of Cisatracurium Besylate
Figure 82. Industry Chain Structure of Cisatracurium Besylate
Figure 83. Channels of Distribution
Figure 84. Global Cisatracurium Besylate Sales Market Forecast by Region (2024-2029)
Figure 85. Global Cisatracurium Besylate Revenue Market Share Forecast by Region (2024-2029)
Figure 86. Global Cisatracurium Besylate Sales Market Share Forecast by Type (2024-2029)
Figure 87. Global Cisatracurium Besylate Revenue Market Share Forecast by Type (2024-2029)
Figure 88. Global Cisatracurium Besylate Sales Market Share Forecast by Application (2024-2029)
Figure 89. Global Cisatracurium Besylate Revenue Market Share Forecast by Application (2024-2029)
